Shawn Kelly
Interventional Cardiology · Great Falls, MTNPI 1932425329
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Edwards Lifesciences at 57.9% of the total. Reporting peaked in 2022 at $2,306 and has fallen 64.2% since, to $825 in 2023. That places this record below the midpoint for interventional cardiology clinicians in MT, where the typical reported total is $5,910.
Across 144 payments — averaging $38.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- E.r. Squibb & Sons, L.L.C.$375
- Actelion Pharmaceuticals US, Inc.$337
- Novartis$331
- Merck$206
- Johnson & Johnson$163
- plus $929 from 20 others
What the payments were for
- Travel & lodging$2,54646%
- Food & beverage$2,91552%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 24 | $3,221 |
| E.r. Squibb & Sons, L.L.C. | 20 | $375 |
| Actelion Pharmaceuticals US, Inc. | 8 | $337 |
| Novartis | 18 | $331 |
| Merck | 9 | $206 |
| Johnson & Johnson | 8 | $163 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $150 |
| Amgen | 11 | $146 |
| AstraZeneca | 9 | $125 |
| Abiomed | 2 | $79 |
| Medtronic(2 entities) | 2 | $72 |
| Preventice Services, LLC | 3 | $42 |
| Pfizer | 3 | $42 |
| W. L. Gore & Associates, Inc. | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Philips North America LLC | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Chiesi USA, Inc. | 1 | $23 |
| GE HealthCare | 1 | $19 |
| Lemaitre Vascular, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Cordis US CORP. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Sanofi | 1 | $12 |
| Cardiovascular Systems Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,562 in reported general payments places this provider in the 45th percentile of 22 interventional cardiology providers in Montana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $41,333 |
| BrilintaTicagrelor | 11 | $10,384 |
| Atorvastatin Calcium | 77 | $1,142 |
| Rosuvastatin Calcium | 64 | $949 |
| Metoprolol Succinate | 58 | $898 |
| ClopidogrelClopidogrel Bisulfate | 71 | $774 |
| Ezetimibe | 26 | $483 |
| Losartan Potassium | 40 | $407 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 50 | $390 |
| Amiodarone Hcl | 12 | $346 |
| Valsartan | 14 | $255 |
| Bisoprolol Fumarate | 15 | $243 |
| Metoprolol Tartrate | 32 | $226 |
| Pravastatin Sodium | 11 | $171 |
| Carvedilol | 24 | $166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $41,33344 claims |
| AstraZenecaBrilinta | $125 | $10,38411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 22 interventional cardiology providers in Montana.
Other interventional cardiology in Great Falls
- Steven GoldbergGreat Falls$134K
- Michael EisenhauerGreat Falls$46K
- Daniel SpoonMissoula$58K
- Robert MinorBillings$46K
- Joshua VogtKalispell$41K
- Claudia Lama von BuchwaldBillings$29K
- Per SommerBillings$27K
- James MadduxMissoula$26K
- Robert TerryBillings$12K
- William HullButte$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.